SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-13-061413
Filing Date
2013-11-14
Accepted
2013-11-14 10:08:47
Documents
10
Period of Report
2013-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v358913_10q.htm 10-Q 903101
2 EXHIBIT 31.1 v358913_ex31-1.htm EX-31.1 9549
3 EXHIBIT 31.2 v358913_ex31-2.htm EX-31.2 9234
4 EXHIBIT 32 v358913_ex32.htm EX-32 6259
  Complete submission text file 0001144204-13-061413.txt   4127297

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT relv-20130930.xml EX-101.INS 516667
6 XBRL TAXONOMY EXTENSION SCHEMA relv-20130930.xsd EX-101.SCH 28737
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE relv-20130930_cal.xml EX-101.CAL 46249
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE relv-20130930_def.xml EX-101.DEF 168131
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE relv-20130930_lab.xml EX-101.LAB 224591
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE relv-20130930_pre.xml EX-101.PRE 198947
Mailing Address 136 CHESTERFIELD INDUSTRIAL BLVD P O BOX 405 CHESTERFIELD MO 63006-0405
Business Address 136 CHESTERFIELD INDUSTRIAL BLVD P O BOX 405 CHESTERFIELD MO 63006-0405 636-537-9715
RELIV INTERNATIONAL INC (Filer) CIK: 0000768710 (see all company filings)

IRS No.: 371172197 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19932 | Film No.: 131217299
SIC: 2834 Pharmaceutical Preparations